Ads
-
Related paper
- THE ROLE OF A NEW BIOMARKER GROWTH DIFFERENTIATION FACTOR 15 IN PROGNOSIS OF PATIENTS WITH ACUTE CORONARY SYNDROME AND TYPE 2 DIABETES MELLITUS
- IMPACT OF TYPE 2 DIABETES MELLITUS ON CLINICAL AND FUNCTIONAL FEATURES AND PROGNOSIS IN PATIENTS WITH ACUTE CORONARY SYNDROME
- Clinical and Functional Features of Acute Coronary Syndrome in Patients with Concomitant Type 2 Diabetes Mellitus
- A study on clinical profile of acute coronary syndrome in type 2 diabetes mellitus patients with relevance to HbA1c
- Growth Differentiation Factor-15 (GDF-15) a Precursory Biomarker for Diabetic Patients with Coronary Artery and Chronic Kidney Disease
- DYNAMICS OF GALECTIN-3 LEVELS IN PATIENTS WITH ACUTE CORONARY SYNDROMES AND 2 TYPE DIABETES MELLITUS UNDER THE INFLUENCE OF EMPAGLIFLOZIN AND TRIMETAZIDINE
- A Novel Biomarker - Heart Type Fattyacid Binding Protein (H-FABP) in Patient with Acute Coronary Syndrome
- Atherogenic Dyslipidemia: An Important Risk Factor for Cardiovascular Disease in Metabolic Syndrome and Type 2 Diabetes Mellitus Patients
- Implication of Plasma miR 122 and miR 151-3p Levels in Diagnosis and Prognosis of Acute Coronary Syndrome Patients
- Correlation between Diabetic Retinopathy and The Severity of Coronary Artery Disease Determined by Coronary Angiography in Patients with Type II Diabetes Mellitus